Incyte Corporation

Anita Swarnakar

Henry Yue

Mariah R Baughn

April J A Hafalia

Monique G Yao

Ameena R Gandhi

Yan Lu

Craig H Ison

Olga Bandman

Preeti G Lal

Neil Burford

Vicki S Elliott

Li Ding

Yuming Xu

Y Tom Tang

Dyung Aina M Lu

Bridget A Warren

Junming Yang

Bao M Tran

Brendan M Duggan

Kimberly J Gietzen

Sally Lee

Madhusudan M Sanjanwala

Michael Thorton

Cynthia D Honchell

Danniel B Nguyen

Narinder K Chawla

Rajagopal Gururajan

Michael B Thornton

Uyen K Tran

Ian J Forsythe

Pei Jin

Shanya D Becha

Reena Khare

Thomas W Richardson

Joseph P Marquis

Soo Yeun Lee

Ernestine A Lee

Wen Luo

Narinder K Walia

Joana X Li

Amy D Wilson

Stephanie Kareht

Kavitha Thangaveln

Narinder K Chawla-Walia

Jayalaxmi Ramkumar

Kavitha Thangavelu

Stephanie K Sapperstein

Vicki S Kaulback

Phillip R Hawkins

Chandra S Arvizu

Xin Jiang

Catherine M Tribouley

Farrah A Khan

Vicki S Elliott Kaulback

Patricia M Lehr-Mason

Ann E Gorvad

Amy E Kable

David Chien

Alan A Jackson

Sean A Bulloch

Jennifer A Griffin

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Antibody to secreted polypeptide

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

CD40-related receptor that binds CD40L

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

Growing community of inventors

San Francisco, CA, United States of America

Anita Swarnakar